Trial Outcomes & Findings for Midvastus Versus Medial Parapatellar Approach for Minimally Invasive Total Knee Arthroplasty (NCT NCT01132378)
NCT ID: NCT01132378
Last Updated: 2014-01-17
Results Overview
The higher the score the better is the result (0-100). The knee society score reflects the outcomes and perception of the patients regarding function and pain
COMPLETED
NA
40 participants
2 year
2014-01-17
Participant Flow
Forty consecutive patients who underwent staged bilateral TKA (within no more than 7 days)were assessed at 2,6, 12 weeks and 6,12, and24 months postoperatively
Forty consecutive patients who underwent staged bilateral Total Knee Arthroplasty were prospectively randomised to receive mini MedialParapatellar Approach in one knee and mini-midvastus approach in the other knee (left or right)within no more than 7 days.
Participant milestones
| Measure |
Mini-midvastus Incision
Total knee arthroplasty : staged bilateral total knee arthroplasty
Forty consecutive patients who underwent staged bilateral Total Knee Arthroplasty were prospectively randomised to receive mini-midvastus approach in one knee and mini-Medial Parapatellar Approachthe in another knee (left or right)within no more than 7 days.
|
|---|---|
|
Overall Study
STARTED
|
40
|
|
Overall Study
COMPLETED
|
40
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Midvastus Versus Medial Parapatellar Approach for Minimally Invasive Total Knee Arthroplasty
Baseline characteristics by cohort
| Measure |
Median Parepatellar Approach or Minimidvastus Approach
n=40 Participants
Total knee arthroplasty : staged bilateral total knee arthroplasty
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
40 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
65.13 years
STANDARD_DEVIATION 6.49 • n=5 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
26 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
40 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 yearThe higher the score the better is the result (0-100). The knee society score reflects the outcomes and perception of the patients regarding function and pain
Outcome measures
| Measure |
Medial Parapatellar Approach
n=40 Participants
Forty consecutive patients who underwent staged bilateral Total Knee Arthroplasty were prospectively randomised to receive mini MedialParapatellar Approach in one knee and mini-midvastus approach in the other knee (left or right)within no more than 7 days.
|
Mini-midvastus Approach
n=40 Participants
Total knee arthroplasty : staged bilateral total knee arthroplasty
|
|---|---|---|
|
Knee Society Score
|
98.70 score
Standard Deviation 2.32
|
99.03 score
Standard Deviation 1.92
|
SECONDARY outcome
Timeframe: 2 yearOutcome measures
Outcome data not reported
Adverse Events
Midvastus or Medial Parapatellar Approach
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
R. David Heekin MD, FACS
Heekin Institute for Orthopaedic Research
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place